Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The "Botanical Drug Market by Type, Source, Therapeutic Application, Formulation, End User, Route Of Administration - Global Forecast 2025-2030" report has...
-
Dublin, April 19, 2022 (GLOBE NEWSWIRE) -- The "Global Botanical and Plant-Derived Drugs Market 2022-2026" report has been added to ResearchAndMarkets.com's offering. The publisher has been...
-
NE PAS DISTRIBUER AUX AGENCES DE PRESSE AMÉRICAINES NI DIFFUSER AUX ÉTATS-UNIS QUÉBEC, 06 août 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian Inc. (« Devonian » ou la « Société ») (TSX...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN THE UNITED STATES. QUEBEC CITY, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. (“Devonian” or the “Corporation”)...
-
NE PAS DISTRIBUER AUX AGENCES DE PRESSE AMÉRICAINES NI DIFFUSER AUX ÉTATS-UNIS Aspri Pharma Canada Inc. agit en tant que souscripteur principalDébentures convertibles non garanties convertibles au...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN THE UNITED STATES. Aspri Pharma Canada Inc. acts as lead subscriberUnsecured Convertible Debentures convertible at a price of...
-
QUÉBEC, 18 juill. 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD), une société pharmaceutique botanique en stade avancé de...
-
QUEBEC CITY, July 18, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSX VENTURE:GSD), a clinical stage botanical pharmaceutical corporation focused on...
-
QUÉBEC, 29 juin 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian Inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD) annonce que le conseil d'administration a approuvé l'octroi d'options...
-
QUEBEC CITY, June 29, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSX VENTURE:GSD) announces that the Board of Directors has approved the grant of options...